AudioCardio

paid

AudioCardio is an FDA-cleared AI diagnostic and digital therapeutic platform offering sound therapy for tinnitus relief and hearing loss. Available as a mobile app and clinical medical devices.

Data & Analytics

AI Models & Infrastructure

Audio Enhancers

About

AudioCardio is a pioneering digital health company that combines artificial intelligence with sound therapy to address hearing loss and tinnitus. The platform encompasses two core product lines: clinical medical devices and a consumer mobile application. On the clinical side, Tinnitogram is an FDA-cleared, AI-driven fine-grain audiometer that measures 67 frequency bands — compared to the industry-standard 6–11 — giving physicians an unprecedented high-resolution view of a patient's hearing thresholds. It identifies hidden hearing loss and tinnitus markers to enable better treatment decisions. REVE134 is an FDA-cleared personalized digital therapeutic that generates customized sound therapies using AudioCardio's patented Threshold Sound Conditioning technology to stimulate damaged auditory frequency bands and relieve tinnitus. For consumers, the AudioCardio mobile app delivers inaudible sound therapies designed to maintain and strengthen hearing while providing tinnitus relief — functioning like physical therapy for the auditory system. Users engage in regular listening sessions, and the app adapts therapies to individual hearing profiles. AudioCardio is ideal for individuals suffering from tinnitus or age-related hearing decline, as well as audiologists and ENT specialists seeking advanced diagnostic and therapeutic tools. The platform bridges the gap between clinical-grade hearing care and accessible consumer wellness, all backed by AI-driven personalization.

Key Features

Tinnitogram Fine-Grain Audiometry: An FDA-cleared AI audiometer that measures 67 frequency bands (vs. the standard 6–11), providing clinicians with high-resolution hearing threshold data and tinnitus marker identification.
REVE134 Personalized Digital Therapeutics: An FDA-cleared device that generates customized sound therapies using patented Threshold Sound Conditioning technology to stimulate damaged frequency bands and relieve tinnitus.
Consumer Mobile App with Sound Therapy: Delivers inaudible, personalized sound therapies via smartphone to maintain and strengthen hearing and provide tinnitus relief — like physical therapy for your ears.
AI-Driven Hearing Diagnostics: Leverages artificial intelligence to uncover hidden hearing loss and identify tinnitus markers that standard audiometric tools typically miss.
Clinically Validated Outcomes: Over 70% of users who completed a minimum of 30 sessions reported positive improvements in hearing or tinnitus symptoms.

Use Cases

Individuals suffering from chronic tinnitus using the mobile app daily for sound-based relief therapy.
Audiologists and ENT physicians deploying Tinnitogram to obtain high-resolution hearing threshold maps and identify hidden hearing loss in patients.
Clinicians using REVE134 to deliver personalized digital sound therapeutics to patients with tinnitus as part of a treatment plan.
Patients with age-related hearing decline using AudioCardio's app as an accessible, at-home hearing maintenance regimen.
Healthcare organizations and hearing clinics integrating AudioCardio's FDA-cleared medical devices into their diagnostic and treatment workflows.

Pros

FDA-Cleared Medical Devices: Both Tinnitogram and REVE134 carry FDA clearance, lending strong clinical credibility to the platform's diagnostics and therapeutics.
Superior Diagnostic Resolution: Measuring 67 frequency bands compared to the industry standard of 6–11 gives audiologists and ENTs a dramatically more detailed picture of a patient's hearing health.
Accessible Consumer Option: The mobile app makes professional-grade sound therapy accessible to everyday users without requiring a clinical visit.
Personalized AI-Powered Therapy: Therapies are tailored to individual hearing profiles using AI, improving relevance and effectiveness compared to one-size-fits-all solutions.

Cons

Niche Application: The platform is narrowly focused on hearing health and tinnitus, making it irrelevant for users without these specific conditions.
Paid Subscription Required: Full access to the mobile app and medical solutions requires payment; no clearly advertised free tier is available.
Not a Medical Substitute: The platform explicitly states it is not a substitute for professional medical advice, which may limit user confidence in self-managed therapy.

Frequently Asked Questions

AudioCardio is a digital health platform that uses AI-driven diagnostics and sound therapy to help maintain hearing and relieve tinnitus. Its mobile app delivers inaudible sound frequencies calibrated to a user's hearing profile, while its medical devices provide clinical-grade audiometry and personalized therapeutics.

Yes. Both the Tinnitogram audiometer and the REVE134 digital therapeutic device are FDA cleared, ensuring they meet regulatory standards for medical safety and effectiveness.

Standard audiometers typically measure 6–11 frequency bands. Tinnitogram measures 67 frequency bands, giving clinicians far greater resolution to identify hidden hearing loss and locate tinnitus markers.

AudioCardio recommends a minimum of 30 sessions, after which more than 70% of users reported positive changes to their hearing or tinnitus. Individual results may vary.

AudioCardio serves two audiences: consumers experiencing tinnitus or hearing decline who want a convenient mobile therapy, and healthcare professionals such as audiologists and ENT specialists who need advanced diagnostic and therapeutic tools for their patients.